Veena Gupta*
Division of Germplasm Conservation,
ICAR-National Bureau of Plant Genetic Resources,
Pusa Campus, New Delhi 110012,
Email veena.gupta@icar.gov.in
Received-08.07.2020, Revised-27.07.2020
Abstract:Medicinal plants sector continues to be the multi-billion dollar market globally. Since transgenic medicinal plants are not accepted in the herbal sector, classical breeding approaches are the only option for the crop improvement programmes. India having about eight per cent of world’s biodiversity including the medicinal plant genetic resources, has the potential of becoming a major global player in market for medicinal plants based herbal formulations, medicines and products. As the demand for herbal medicines is growing in developing countries and consumers in developed countries are averted with modern medications are seeking alternatives medicines. It has also revived the interest by the multinational pharmaceutical industry in bio-prospecting (Singh, 2006).
Keywords: Cultivation, Herbal medicine, Medicinal plants
References
Kak, Anjali and Veena, Gupta (2017). Inventory of Registered Crop Germplasm (2015-2017). ICAR-National Bureau of Plant Genetic Resources, PusaCampus, Indian Council of Agricultural Research (ICAR), New Delhi-110 012, 74p.
NBPGR Website http://www.nbpgr.ernet.in:8080/ircg/index.htmon(accessed on 02-07-2020)
Sahoo, Niharika and Padmavati, Manchikanti (2013). Herbal Drug Regulation and Commercialisation: An Indian Industry Perspective. J. Alternative and complementary Medicine.Vol.19(12): 957-963. Doi: 10.1089/acm.2012.0275
Singh, H. (2006). Prospects and challenges for harnessing opportunities in medicinal plants sector in India. LEAD J; vol.2:198–211.